Glaser Daniel S 4

What Happened

• Daniel S. Glaser, a non-management director of MetLife, received an award of 721 shares of MetLife common stock on April 1, 2026. The shares were recorded at $71.17 per share, totaling $51,314, and were acquired as part of director compensation (transaction code A — award/acquisition). This was a compensation receipt, not an open-market purchase or sale.

Key Details

• Transaction date and terms: 2026-04-01 — 721 shares @ $71.17 per share = $51,314.
• SEC filing: Form 4 filed 2026-04-03 (appears timely; Form 4 is generally due within two business days).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: (F1) These shares represent a portion of non-management director retainer fees paid in stock; Glaser elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. (F2) The shares are held in a GRAT (grantor retained annuity trust).
• No 10b5-1 plan, sale, or option exercise was reported for this transaction.

Context

• This is routine director compensation structured as deferred stock and held in a trust; such awards reflect pay arrangements rather than a direct bullish or bearish signal about company stock. For retail investors, director awards are informative about compensation practices but should not be interpreted alone as insider sentiment or trading intent.